T1	Participants 142 194	patients with the acquired immunodeficiency syndrome
T2	Participants 551 721	310 adults with AIDS who had recently recovered from an initial episode of PCP and had no treatment-limiting toxic effects of trimethoprim-sulfamethoxazole or pentamidine
T3	Participants 723 739	All the patients
T4	Participants 968 980	participants
T5	Participants 1602 1608	groups
T6	Participants 1870 1976	19 serious bacterial infections in the trimethoprim-sulfamethoxazole group and 38 in the pentamidine group
T7	Participants 2048 2095	those assigned to trimethoprim-sulfamethoxazole
T8	Participants 2124 2171	patients with AIDS who are receiving zidovudine
